Merkel Cell Carcinoma - 3 Studies Found
| RECRUITING |
: Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer : Merkel Cell Carcinoma : 2024-10-31 : Pembrolizumab 400mg IV |
| RECRUITING |
: Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2024-10-31 : 400mg IV |
| RECRUITING |
: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma : Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8 : 2024-10-31 : Undergo tumor biopsy |